Survival by Response to First-line Platinum-Based Therapy Among Patients With Extensive Disease Small Cell Lung Cancer

被引：0
|
作者：
Danese, M. [1 ]
Gleeson, M. [1 ]
Lubeck, D. [1 ]
Penrod, J. [2 ]
Korytowsky, B. [2 ]
Yuan, Y. [2 ]
机构：
[1] Outcomes Insights Inc, Westlake Village, CA USA
[2] Bristol Myers Squibb, Princeton, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
small cell lung cancer; overall survival; platinum-based therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.15-003
引用
收藏
页码：S2043 / S2043
页数：1
相关论文
共 50 条
  • [1] Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival
    Sirohi, Bhawna
    Ashley, Sue
    Norton, Alison
    Popat, Sanjay
    Hughes, Sarah
    Papadopoulos, Panagiotous
    Priest, Kathryn
    O'Brien, Mary
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 735 - 740
  • [2] A phase III study of rovalpituzumab tesirine maintenance therapy following first-line platinum-based chemotherapy in patients with extensive disease small cell lung cancer (ED SCLC).
    Komarnitsky, Philip B.
    Lee, Ho-Jin
    Shah, Manan
    Wong, Shekman
    Gauthier, Sanja
    Dziubinski, Juliann
    Osbaugh, Stacy
    Zhang, Fan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Pretreatment Inflammatory Indexes are Associated with Response to First-Line Platinum-Based Chemotherapy and Prognosis of Small Cell Lung Cancer Patients
    Inanc, Mevlude
    Bozkurt, Oktay
    Ocak Duran, Ayse
    Ozkan, Metin
    Altinbas, Mustafa
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (02): : 79 - 87
  • [4] Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
    Xu, X. -L.
    Yao, Y. -L.
    Xu, W. -Z.
    Feng, J. -G.
    Mao, W. -M.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 3525 - 3533
  • [5] Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer
    Cheng, Ting
    Dai, Xin
    Zhou, Dan-Li
    Lv, Yang
    Miao, Li-Yun
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 7
  • [6] Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer
    Ting Cheng
    Xin Dai
    Dan-Li Zhou
    Yang Lv
    Li-Yun Miao
    Medical Oncology, 2015, 32
  • [7] Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy
    Evans, Tracey L.
    Cho, Byoung Chul
    Udud, Katalin
    Fischer, Juergen R.
    Shepherd, Frances A.
    Martinez, Pablo
    Ramlau, Rodryg
    Syrigos, Konstantinos N.
    Shen, Liji
    Chadjaa, Mustapha
    Wolf, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (08) : 1221 - 1228
  • [8] Safety and efficacy of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer
    Liu, C.
    Wang, J.
    Chang, J.
    Wu, X.
    Yu, H.
    Sun, S.
    Zhao, X.
    Wang, H.
    Qiao, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1042 - S1042
  • [9] Amrubicin monotherapy in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: updated results of a phase 2 trial
    Ettinger, David S.
    Jotte, Robert M.
    Paul, Lorigan
    Gupta, Vicram
    Garbo, Lawrence
    Alemany, Carlos
    Spigel, David R.
    Dudek, Arkadiusz Z.
    Salgia, Ravi
    McNally, Richard
    Renschler, Markus
    Oliver, Jennifer W.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S398 - S399
  • [10] Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Wilop, Stefan
    Crysandt, Martina
    Bendel, Michael
    Mahnken, Andreas H.
    Osieka, Reinhard
    Jost, Edgar
    ONKOLOGIE, 2008, 31 (12): : 665 - 670
12345